The UK Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have opened a call for evidence to evaluate resources produced under the Wellcome-funded Digital Mental Health Technologies (DMHT) programme. The survey opened on 5 November 2026 and will remain open until 26 February 2027.
The two bodies are seeking feedback from a broad group of stakeholders, including developers and manufacturers of digital mental health technologies, healthcare professionals, researchers, policymakers, regulators, people with lived experience of mental health conditions, carers and members of the public.
Scope of the evaluation
According to the MHRA and NICE, the survey forms part of the programme's Phase 1 evaluation. It is intended to establish how the resources have been received and used across the sector, and in particular whether they have influenced users' knowledge, confidence, decision-making and professional practice.
The resources were created to support the safe development, regulation, evaluation and adoption of digital mental health technologies, including mental health apps and other digital tools. Findings from the survey will help determine whether the Phase 1 outputs met their intended objectives and will inform the future direction of Phase 2 of the DMHT programme.
The agencies encourage participation regardless of whether respondents have engaged extensively, minimally or not at all with the existing materials. They say the feedback will help identify strengths, highlight areas for improvement and shape future work aimed at improving the safety and effectiveness of digital mental health technologies.